Results 231 to 240 of about 88,489 (340)

The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.
Giovanni Battista Bonfioli   +11 more
wiley   +1 more source

Plasma Atrial Natriuretic Peptide Predicts Oxidized Low-Density Lipoprotein Levels in Type 2 Diabetes Mellitus Patients Independent of Circulating Adipokine and Cytokine. [PDF]

open access: yesInt J Mol Sci
Bakillah A   +9 more
europepmc   +1 more source

Degradation and clearance of atrial natriuretic factors [PDF]

open access: yes, 1990
Adnot   +102 more
core   +1 more source

Atrial natriuretic peptide concentrations in pre-eclampsia:: Authors' reply [PDF]

open access: green, 1987
J. K. Thomsen   +4 more
openalex   +1 more source

Microvascular obstruction in cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Aims Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the prevalence of microvascular obstruction (MVO) in patients with CA and to assess the association between MVO and prognosis ...
Lucrezia Netti   +19 more
wiley   +1 more source

Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity. [PDF]

open access: yesSci Adv
Carper D   +40 more
europepmc   +1 more source

Effects of atrial natriuretic peptide on renal function and renin release in the isolated perfused rat kidney.

open access: bronze, 1987
Shosaku Narumi   +6 more
openalex   +2 more sources

Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts

open access: yesEuropean Journal of Heart Failure, EarlyView.
Markers of progression to heart failure (HF). Gal‐4, galectin‐4; GDF‐15, growth differentiation factor 15; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; ST2, suppression of tumorigenicity‐2. ABSTRACT Aims Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart ...
Anna Dieden   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy